UDPG/P2Y14-STAT1 axis mediates LPS-induced reactive astrogliosis
Astrocytes play a vital role in neuroinflammatory processes within the central nervous system (CNS). Increasing evidence suggests that purinergic G protein-coupled receptor P2Y<sub>14</sub> is associated with neuroinflammation. However, the expression, distribution, and function of P2Y<sub>14</sub> in astrocytes remain unclear. This study aimed to investigate the expression of P2Y<sub>14</sub> receptors in astrocytes and their regulatory role in astrocytic inflammatory responses. P2Y<sub>14</sub> expression was confirmed in primary astrocytes isolated from the mouse cerebral cortex using immunofluorescence techniques. Western blot and RT-qPCR analyses showed that lipopolysaccharide (LPS) stimulation significantly increased P2Y<sub>14</sub> expression in astrocytes. The antagonist of P2Y<sub>14</sub> receptor, 4-(piperidin-4-yl)-phenyl)-7-(4-(trifluoromethyl)-phenyl2-naphthoic acid (PPTN) reduced glial fibrillary acidic protein (GFAP) expression, while the agonist of P2Y<sub>14</sub> receptor, uridine diphosphate glucose (UDPG) promoted it in astrocytes. Mechanistically, PPTN inhibited the expression of signal transducer and activator of transcription 1 (STAT1) and its phosphorylated form (p-STAT1), while UDPG enhanced the activation of STAT1/p-STAT1. Treatment with the P2Y<sub>14</sub> antagonist PPTN resulted in significant inhibition of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-α) release. By contrast, stimulation of the P2Y<sub>14</sub> receptor with its agonist UDPG induced a substantial increase in the levels of these inflammatory mediators. These results were further validated in the cell line of mouse astrocyte C8-D1A using pharmacological approaches and lentiviral transduction to modulate P2Y<sub>14</sub> expression. This study confirmed that astrocytes express functional P2Y<sub>14</sub> receptors and demonstrated their key role in regulating astrocyte activation and inflammatory responses. This regulation may be achieved through the UDPG/P2Y<sub>14</sub>-STAT1 signaling axis, which provides a new molecular basis for understanding the regulatory mechanisms of astrocytic inflammatory responses.
Authors
- Yong Tang (ORCID: https://orcid.org/0000-0002-2543-066X)
- Péter Illés (ORCID: https://orcid.org/0000-0003-0484-9389)
- Patrizia Rubini
- Peng Yang (ORCID: https://orcid.org/0000-0003-1535-2538)
- Yuan-Hong Deng
- Xiao Ran (ORCID: https://orcid.org/0000-0001-5025-2538)
- Si‐Si Lin
- Wenjing Ren
- Mengyao Wang (ORCID: https://orcid.org/0009-0005-5135-0224)
Institutions
- Chengdu University of Traditional Chinese Medicine (CN)
- Leipzig University (DE)
Publication Details
- Journal
- Neuropharmacology
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1016/j.neuropharm.2025.110723
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00